Mobile

A randomized, multicentre, open-label, 6-month study to explore the efficacy and safety of enteric coated mycophenolate sodium (Myfortic) in combination with two corticosteroid regimens for the treatm...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-002107-13

A randomized, multicentre, open-label, 6-month study to explore the efficacy and safety of enteric coated mycophenolate sodium (Myfortic) in combination with two corticosteroid regimens for the treatment of lupus nephritis

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to explore in non-inferior efficacy of Myfortic administered at a dose of 2160mg/day in combination with reduced corticosteroid regimen compared to the combination with a standard corticosteroid regimen where efficacy measure is defined as the proportion of patients in complete remission after 24 weeks of treatment

Critère d'inclusion

  • Systemic Lupus Nephritis

Liens